Visit https://www.peervoice.com/XMS860 to view the entire programme with slides. After completing “Exploring Early LDL-C Lowering in Patients With Recent MI to Reduce Future Events”, participants will be able to: Identify patients with recent myocardial infarction (MI) at high risk of cardiovascular (CV) events who may benefit from PCSK-9 inhibitors; Discuss optimal multidisciplinary management of patients following MI, based on the latest evidence and recommendations; Identify the key changes to the CCS 2021 dyslipidemia guidelines with a focus on post myocardial infarction (MI); Apply the new dyslipidemia guidelines to clinical practice in patients with a recent MI.